PT98156A - Um processo de preparacao de uma composicao de vacina - Google Patents
Um processo de preparacao de uma composicao de vacinaInfo
- Publication number
- PT98156A PT98156A PT98156A PT9815691A PT98156A PT 98156 A PT98156 A PT 98156A PT 98156 A PT98156 A PT 98156A PT 9815691 A PT9815691 A PT 9815691A PT 98156 A PT98156 A PT 98156A
- Authority
- PT
- Portugal
- Prior art keywords
- vaccine composition
- preparing
- liposome
- oil
- component
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54658590A | 1990-06-29 | 1990-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
PT98156A true PT98156A (pt) | 1992-04-30 |
PT98156B PT98156B (pt) | 1998-12-31 |
Family
ID=24181076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98156A PT98156B (pt) | 1990-06-29 | 1991-06-28 | Um processo de preparacao de uma composicao de vacina |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0489153B1 (pt) |
JP (1) | JP2502234B2 (pt) |
AT (1) | ATE185486T1 (pt) |
AU (1) | AU654824B2 (pt) |
BR (1) | BR9106604A (pt) |
CA (1) | CA2086094C (pt) |
DE (1) | DE69131709T2 (pt) |
DK (1) | DK0489153T3 (pt) |
ES (1) | ES2138588T3 (pt) |
FI (1) | FI925835A (pt) |
GR (1) | GR3031528T3 (pt) |
HU (1) | HU220136B (pt) |
IE (1) | IE912286A1 (pt) |
NO (1) | NO924858L (pt) |
OA (1) | OA09800A (pt) |
PT (1) | PT98156B (pt) |
WO (1) | WO1992000081A1 (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2692149B1 (fr) * | 1992-06-12 | 1995-06-09 | Vacsyn France Sa | Composition adjuvante de l'immunite humorale et a mediation cellulaire n'induisant pas de reponse vis-a-vis de determinants auto-antigeniques. |
EP0669941A1 (en) * | 1992-11-02 | 1995-09-06 | NICOLAU, Yves Claude | Method of reducing multidrug resistance in cells and tissues |
WO1995011700A1 (en) * | 1993-10-29 | 1995-05-04 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
US5961970A (en) * | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
DE69526636T3 (de) * | 1994-07-29 | 2006-11-23 | Innogenetics N.V. | Gereinigte hepatitis-c-virus hüllproteine zur diagnostischen und therapeutischen verwendung |
AU5978596A (en) * | 1995-06-07 | 1996-12-30 | U.S. Department Of The Army | Liposomes containing human immunodeficiency virus glycoprote in and methods for use thereof |
US5820880A (en) * | 1995-06-07 | 1998-10-13 | The United States Of America As Represented By The Secretary Of The Army | Liposomal formulation |
US7393630B2 (en) | 1997-12-16 | 2008-07-01 | Novartis Vaccines And Diagnostics, Inc. | Use of microparticles combined with submicron oil-in-water emulsions |
DE69804671T2 (de) | 1997-12-16 | 2002-11-21 | Chiron Corp N D Ges D Staates | Verwendung von mikropartikeln mit submikron öl/wasser emulsionen |
DE60020677T2 (de) * | 1999-02-26 | 2006-05-04 | Chiron Corp., Emeryville | Mikroemulsionen mit adsorbierten makromolekülen und mikropartikeln |
CA2428103C (en) | 2000-11-07 | 2015-06-09 | Immunovaccine Technologies Inc. | Vaccines with enhanced immune response and methods for their preparation |
EP1415648B1 (en) * | 2001-07-13 | 2006-11-22 | NanoCarrier Co., Ltd. | Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof |
KR20030097099A (ko) * | 2002-06-19 | 2003-12-31 | 현대자동차주식회사 | 저압 주조를 위한 금형의 용탕 충진 속도 측정장치 |
US8034378B2 (en) * | 2002-12-27 | 2011-10-11 | Novartis Vaccines And Diagnostics, Inc | Immunogenic compositions containing phospholipid |
CA2523032A1 (en) * | 2005-10-07 | 2007-04-07 | Immunovaccine Technologies Inc. | Vaccines for cancer therapy |
CA2700808C (en) | 2007-09-27 | 2017-11-14 | Immunovaccine Technologies Inc. | Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
WO2009146523A1 (en) | 2008-06-05 | 2009-12-10 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
CA2762179A1 (en) * | 2009-05-18 | 2010-11-25 | Sigmoid Pharma Limited | Composition comprising oil drops |
CA2803282C (en) | 2009-07-06 | 2018-05-01 | David E. Anderson | Methods for preparing vesicles and formulations produced therefrom |
CN102482666B (zh) | 2009-07-06 | 2017-02-08 | 变异生物技术公司 | 制备囊泡的方法和由其产生的制剂 |
WO2012006367A2 (en) * | 2010-07-06 | 2012-01-12 | Variation Biotechnologies, Inc. | Compositions and methods for treating influenza |
CA2862864C (en) | 2011-01-13 | 2018-12-11 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
JP6240077B2 (ja) | 2011-10-06 | 2017-11-29 | イムノバクシーン・テクノロジーズ・インコーポレイテッドImmunovaccine Technologies Inc. | Tlr2を活性化するか、またはその活性を増加させるアジュバントを含むリポソーム組成物およびその使用 |
CA2894442C (en) | 2012-01-12 | 2020-01-21 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
WO2013111012A2 (en) | 2012-01-27 | 2013-08-01 | Variation Biotechnologies, Inc. | Methods and compositions for therapeutic agents |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4199565A (en) * | 1979-03-26 | 1980-04-22 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
HU184141B (en) * | 1979-12-27 | 1984-07-30 | Human Oltoanyagtermelo | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
US4772466A (en) * | 1983-08-22 | 1988-09-20 | Syntex (U.S.A.) Inc. | Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants |
US4606918A (en) * | 1983-08-22 | 1986-08-19 | Syntex (U.S.A.) Inc. | Polyoxypropylene-polyoxyethylene block polymer based adjuvants |
JPS6137738A (ja) * | 1984-07-31 | 1986-02-22 | Tetsuo Nakamura | B型肝炎ワクチン |
-
1991
- 1991-06-25 AU AU83230/91A patent/AU654824B2/en not_active Ceased
- 1991-06-25 ES ES91914563T patent/ES2138588T3/es not_active Expired - Lifetime
- 1991-06-25 JP JP3513457A patent/JP2502234B2/ja not_active Expired - Fee Related
- 1991-06-25 EP EP91914563A patent/EP0489153B1/en not_active Expired - Lifetime
- 1991-06-25 WO PCT/US1991/004532 patent/WO1992000081A1/en active IP Right Grant
- 1991-06-25 CA CA002086094A patent/CA2086094C/en not_active Expired - Fee Related
- 1991-06-25 HU HU9204136A patent/HU220136B/hu not_active IP Right Cessation
- 1991-06-25 BR BR919106604A patent/BR9106604A/pt unknown
- 1991-06-25 AT AT91914563T patent/ATE185486T1/de not_active IP Right Cessation
- 1991-06-25 DK DK91914563T patent/DK0489153T3/da active
- 1991-06-25 DE DE69131709T patent/DE69131709T2/de not_active Expired - Fee Related
- 1991-06-28 IE IE228691A patent/IE912286A1/en not_active Application Discontinuation
- 1991-06-28 PT PT98156A patent/PT98156B/pt not_active IP Right Cessation
-
1992
- 1992-12-15 NO NO92924858A patent/NO924858L/no unknown
- 1992-12-22 FI FI925835A patent/FI925835A/fi not_active Application Discontinuation
- 1992-12-22 OA OA60322A patent/OA09800A/en unknown
-
1999
- 1999-10-14 GR GR990402355T patent/GR3031528T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO924858D0 (no) | 1992-12-15 |
JPH06504759A (ja) | 1994-06-02 |
PT98156B (pt) | 1998-12-31 |
ES2138588T3 (es) | 2000-01-16 |
CA2086094C (en) | 2000-05-30 |
AU654824B2 (en) | 1994-11-24 |
HU9204136D0 (en) | 1993-11-29 |
NO924858L (no) | 1993-02-25 |
JP2502234B2 (ja) | 1996-05-29 |
BR9106604A (pt) | 1993-06-22 |
OA09800A (en) | 1994-04-15 |
FI925835A0 (fi) | 1992-12-22 |
CA2086094A1 (en) | 1991-12-30 |
DK0489153T3 (da) | 2000-01-24 |
AU8323091A (en) | 1992-01-23 |
WO1992000081A1 (en) | 1992-01-09 |
FI925835A (fi) | 1992-12-22 |
IE912286A1 (en) | 1992-01-01 |
HUT67055A (en) | 1995-01-30 |
DE69131709T2 (de) | 2000-05-25 |
GR3031528T3 (en) | 2000-01-31 |
EP0489153A4 (en) | 1993-04-21 |
HU220136B (hu) | 2001-11-28 |
ATE185486T1 (de) | 1999-10-15 |
EP0489153B1 (en) | 1999-10-13 |
DE69131709D1 (de) | 1999-11-18 |
EP0489153A1 (en) | 1992-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT98156A (pt) | Um processo de preparacao de uma composicao de vacina | |
LU91485I2 (fr) | Vaccin adjuvant grippal dans lequel l'adjuvant estune émulsion huile-dans-eau comprenant du squalèn e, du DL-a-tocophérol et du polysorbate 80 | |
DE3787663D1 (de) | Impfstofformulierung. | |
BR9510223A (pt) | Adjuvante para vacinas utilização de um polissacarideo lipidico processo para preparar uma cacina em emulsão e vacina | |
EA199700272A1 (ru) | Вакцины, содержащие сапонин и стерин | |
HUP9901901A2 (hu) | Hepatitis C elleni vakcinák | |
DE69533693D1 (de) | Impfstoffe, die paucilamelläre Lipidvesikel als Adjuvans enthalten | |
DE69112634D1 (de) | Immunogene komplexe, insbesondere iscoms. | |
DE3473825D1 (en) | Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained | |
DE3380053D1 (en) | Conjugates of haptenes and muramyl peptides having an immunogenic activity, and compositions containing them | |
ES2097840T3 (es) | Adyuvante de vacuna que comprende un tetrapoliol. | |
SE9600646D0 (sv) | Vaccin | |
DK0563288T3 (da) | Immunopotentiering af vacciner, navnlig svinepleuropneumoniavacciner | |
ES2053402A1 (es) | Metodo de preparacion de vacunas inactivadas y vacunas vivas adyuvantadas asi como las vacunas obtenidas por dicho metodo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB1A | Laying open of patent application |
Effective date: 19911127 |
|
FG3A | Patent granted, date of granting |
Effective date: 19980902 |
|
MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20040331 |